We are live on
!
Find out more
NTC
NF Trinity Capital Portfolio holdings
AUM
$626M
1-Year Est. Return
3.16%
This Fund
S&P 500
This Quarter
Est. Return
+9.73%
1 Year Est. Return
+3.16%
3 Year Est. Return
+49.61%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$700M
AUM Growth
-$4.98M
(-0.71%)
Cap. Flow
-$12M
Cap. Flow
% of AUM
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
65.48%
Holding
53
New
8
Increased
9
Reduced
3
Closed
5
Top Buys
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$9.54M |
| 2 |
Citigroup
C
|
+$8.53M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$7.03M |
| 4 |
JD.com
JD
|
+$6.01M |
| 5 |
Amazon
AMZN
|
+$5.11M |
Top Sells
| 1 |
Baidu
BIDU
|
+$24.6M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$9.72M |
| 3 |
Bank of America
BAC
|
+$8.01M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
+$5.72M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$4.84M |
Sector Composition
| 1 | Communication Services | 25.8% |
| 2 | Consumer Discretionary | 20.6% |
| 3 | Healthcare | 12.96% |
| 4 | Technology | 12.44% |
| 5 | Financials | 11.23% |
Similar funds
SGAM
ACM
TL
DSI
SCA
SHCM
IAS
MFBTD
NF Trinity Capital's Q3 2017 Portfolio in Review
As of Q3 2017, NF Trinity Capital held 53 positions worth $700M, down 0.71% from $705M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
NF Trinity Capital's Q3 2017 filing shows 8 new, 9 increased, 3 reduced and 5 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 119,000 shares worth $10.3M. The largest sale was Baidu, an estimated $24.6M.
By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- NF Trinity Capital's largest Q3 2017 buy was State Street SPDR S&P Biotech ETF: 119,000 shares worth $10.3M.
- NF Trinity Capital added most to Citigroup in Q3 2017, an estimated $8.53M increase.
- NF Trinity Capital's biggest Q3 2017 reduction was Baidu, cutting an estimated $24.6M.
- NF Trinity Capital fully exited Acadia Pharmaceuticals in Q3 2017, selling an estimated $5.72M.
- NF Trinity Capital's ten largest holdings make up 65% of its $700M portfolio in Q3 2017.
- NF Trinity Capital opened 8 new positions and closed 5 in Q3 2017.
- NF Trinity Capital's portfolio value fell 0.71% quarter-over-quarter to $700M.
Based on NF Trinity Capital's 13F filing for Q3 2017, filed 7 Nov 2017.